Empagliflozin in posttransplantation diabetes mellitus: A prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety

The safety and efficacy of sodium‐glucose cotransporter 2 inhibitors in posttransplantation diabetes mellitus is unknown. We converted stable kidney transplant patients to 10 mg empagliflozin, aiming at replacing their insulin therapy (<40 IU/d). N = 14 participants (the required sample size) com...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwaiger, Elisabeth, Burghart, Lukas, Signorini, Lorenzo, Ristl, Robin, Kopecky, Chantal, Tura, Andrea, Pacini, Giovanni, Wrba, Thomas, Antlanger, Marlies, Schmaldienst, Sabine, Werzowa, Johannes, Säemann, Marcus D., Hecking, Manfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590167/
https://www.ncbi.nlm.nih.gov/pubmed/30585690
http://dx.doi.org/10.1111/ajt.15223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590167/
https://www.ncbi.nlm.nih.gov/pubmed/30585690
http://dx.doi.org/10.1111/ajt.15223

Ejemplares similares